Brind.

Christophe Weber was appointed as President and CEO of Takeda Pharmaceutical Company.

4 reports, 3 independent Updated Sep 9
Gone quiet
Reports
4
Developments
3
Repetition
25%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Christophe Weber was appointed as President and CEO of Takeda Pharmaceutical Company.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Leadership transition at Takeda: Julie Kim appointed CEO, Christophe Weber retires.1 source
  2. Weber retires from Takeda; Julie Kim appointed as President and CEO.1 source
  3. Weber takes over as CEO of Takeda Pharmaceutical Company.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • montrealgazette.com
  • finanznachrichten.de
  • Business WireTakeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1 – Both Phase 3 Studies Met all Primary and Secondary Endpoints Demonstrating Statistic
1 more outlet ran the same wire story